{
    "Trade/Device Name(s)": [
        "Freestyle Precision Pro Blood Glucose and \u03b2-Ketone Monitoring System"
    ],
    "Submitter Information": "Abbott Diabetes Care Inc.",
    "510(k) Number": "K130094",
    "Predicate Device Reference 510(k) Number(s)": [
        "K080960"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR",
        "JQP",
        "JIN"
    ],
    "Summary Letter Date": "June 27, 2013",
    "Summary Letter Received Date": "May 28, 2013",
    "Submission Date": "May 24, 2013",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1435",
        "21 CFR 862.2100"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Ketones (Nonquantitative) Test System",
        "Calculator/data processing module, for clinical use"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose",
        "\u03b2-Ketone (beta-hydroxybutyrate)"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood",
        "Venous whole blood",
        "Arterial whole blood",
        "Neonatal whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Freestyle Precision Pro Blood Glucose and \u03b2-Ketone Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Glucose Dehydrogenase (NAD dependent) biosensor",
        "Nitroprusside (for ketones) biosensor"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip"
    ],
    "Document Summary": "FDA 510(k) summary for Freestyle Precision Pro Blood Glucose and \u03b2-Ketone Monitoring System for quantitative measurement of glucose and \u03b2-ketone in whole blood samples in professional healthcare settings.",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary, venous, arterial, and neonatal whole blood, and \u03b2-ketone in fresh capillary, venous, arterial, and neonatal whole blood (within 30 minutes), for multiple-patient use in professional healthcare settings as an aid to monitor effectiveness of diabetes control; not for diagnosis or screening of diabetes.",
    "fda_folder": "Clinical Chemistry"
}